Safety and pharmacokinetics of SOR102, an oral bispecific inhibitor of TNF and interleukin-23 in healthy participants and patients with ulcerative colitis: a first-in-human, double-blind, randomised, placebo-controlled, phase 1 trial
Vipul Jairath,Silvio Danese,Geert R D'Haens,Brian G Feagan,Laurent Peyrin-Biroulet,Bruce E. Sands,Ingrid Gaemers,Matt Westfall,Allyson Q. Terry,Kevin J. Roberts,Sara Barbat,Pamela Wedel,Jacqueline M. Benson,Carlos Sattler
PDF的下载单位、IP信息已删除
(2025-6-4)
Copyright
Kao
无极微光
cdercder
yjh123
OK
keven
Nole
小花
乐空思
kk
Criminology34
GingerF
liuzhuohao
sagitar
伶俐妙海
arniu2008
dew
囧囧
YEZI
皖公网安备34019202002308
